BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 20488164)

  • 21. A chimeric humanized single-chain antibody against the type I insulin-like growth factor (IGF) receptor renders breast cancer cells refractory to the mitogenic effects of IGF-I.
    Sachdev D; Li SL; Hartell JS; Fujita-Yamaguchi Y; Miller JS; Yee D
    Cancer Res; 2003 Feb; 63(3):627-35. PubMed ID: 12566306
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypoxia-inducible factor-1alpha and hypoxia-inducible factor-2alpha are expressed in kaposi sarcoma and modulated by insulin-like growth factor-I.
    Catrina SB; Botusan IR; Rantanen A; Catrina AI; Pyakurel P; Savu O; Axelson M; Biberfeld P; Poellinger L; Brismar K
    Clin Cancer Res; 2006 Aug; 12(15):4506-14. PubMed ID: 16899596
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Insulin-like growth factor-I receptor blockade by a specific tyrosine kinase inhibitor for human gastrointestinal carcinomas.
    Piao W; Wang Y; Adachi Y; Yamamoto H; Li R; Imsumran A; Li H; Maehata T; Ii M; Arimura Y; Lee CT; Shinomura Y; Carbone DP; Imai K
    Mol Cancer Ther; 2008 Jun; 7(6):1483-93. PubMed ID: 18566219
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ectopic decorin expression up-regulates VEGF expression in mouse cerebral endothelial cells via activation of the transcription factors Sp1, HIF1alpha, and Stat3.
    Santra M; Santra S; Zhang J; Chopp M
    J Neurochem; 2008 Apr; 105(2):324-37. PubMed ID: 18021292
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Co-administration of NVP-AEW541 and dasatinib induces mitochondrial-mediated apoptosis through Bax activation in malignant human glioma cell lines.
    Premkumar DR; Jane EP; Pollack IF
    Int J Oncol; 2010 Sep; 37(3):633-43. PubMed ID: 20664932
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Xanthine oxidase-dependent regulation of hypoxia-inducible factor in cancer cells.
    Griguer CE; Oliva CR; Kelley EE; Giles GI; Lancaster JR; Gillespie GY
    Cancer Res; 2006 Feb; 66(4):2257-63. PubMed ID: 16489029
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phosphatidylinositol 3-kinase and mek1/2 are necessary for insulin-like growth factor-I-induced vascular endothelial growth factor synthesis in prostate epithelial cells: a role for hypoxia-inducible factor-1?
    Burroughs KD; Oh J; Barrett JC; DiAugustine RP
    Mol Cancer Res; 2003 Feb; 1(4):312-22. PubMed ID: 12612059
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Insulin-like growth factors inhibit dendritic cell-mediated anti-tumor immunity through regulating ERK1/2 phosphorylation and p38 dephosphorylation.
    Huang CT; Chang MC; Chen YL; Chen TC; Chen CA; Cheng WF
    Cancer Lett; 2015 Apr; 359(1):117-26. PubMed ID: 25592043
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Down-regulation of type I insulin-like growth factor receptor increases sensitivity of breast cancer cells to insulin.
    Zhang H; Pelzer AM; Kiang DT; Yee D
    Cancer Res; 2007 Jan; 67(1):391-7. PubMed ID: 17210722
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IGF-1 induced vascular endothelial growth factor secretion in head and neck squamous cell carcinoma.
    Slomiany MG; Black LA; Kibbey MM; Day TA; Rosenzweig SA
    Biochem Biophys Res Commun; 2006 Apr; 342(3):851-8. PubMed ID: 16499871
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cell proliferation and migration in glioblastoma multiforme cell lines are influenced by insulin-like growth factor I in vitro.
    Schlenska-Lange A; Knüpfer H; Lange TJ; Kiess W; Knüpfer M
    Anticancer Res; 2008; 28(2A):1055-60. PubMed ID: 18507054
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PI3K/PTEN/Akt pathway status affects the sensitivity of high-grade glioma cell cultures to the insulin-like growth factor-1 receptor inhibitor NVP-AEW541.
    Hägerstrand D; Lindh MB; Peña C; Garcia-Echeverria C; Nistér M; Hofmann F; Ostman A
    Neuro Oncol; 2010 Sep; 12(9):967-75. PubMed ID: 20378689
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of breast cancer cells by IGF1R tyrosine kinase inhibitor combined with conventional systemic drugs.
    Hartog H; Van Der Graaf WT; Boezen HM; Wesseling J
    Anticancer Res; 2012 Apr; 32(4):1309-18. PubMed ID: 22493363
    [TBL] [Abstract][Full Text] [Related]  

  • 34. RT-PCR-based tyrosine kinase display profiling of canine melanoma: IGF-1 receptor as a potential therapeutic target.
    Thamm DH; Huelsmeyer MK; Mitzey AM; Qurollo B; Rose BJ; Kurzman ID
    Melanoma Res; 2010 Feb; 20(1):35-42. PubMed ID: 19949352
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activation of the TGFalpha autocrine loop is downstream of IGF-I receptor activation during mitogenesis in growth factor dependent human colon carcinoma cells.
    Wang D; Patil S; Li W; Humphrey LE; Brattain MG; Howell GM
    Oncogene; 2002 Apr; 21(18):2785-96. PubMed ID: 11973637
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Insulin-like growth factor-type 1 receptor inhibitor NVP-AEW541 enhances radiosensitivity of PTEN wild-type but not PTEN-deficient human prostate cancer cells.
    Isebaert SF; Swinnen JV; McBride WH; Haustermans KM
    Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):239-47. PubMed ID: 21816290
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of biliary tract cancer with NVP-AEW541: mechanisms of action and resistance.
    Wolf S; Lorenz J; Mössner J; Wiedmann M
    World J Gastroenterol; 2010 Jan; 16(2):156-66. PubMed ID: 20066734
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of insulin-like growth factor-1 receptor inhibition in mesothelioma. Thoracic Surgery Directors Association Resident Research Award.
    Whitson BA; Jacobson BA; Frizelle S; Patel MR; Yee D; Maddaus MA; Kratzke RA
    Ann Thorac Surg; 2006 Sep; 82(3):996-1001; discussion 1001-2. PubMed ID: 16928523
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhanced efficacy of IGF1R inhibition in pediatric glioblastoma by combinatorial targeting of PDGFRα/β.
    Bielen A; Perryman L; Box GM; Valenti M; de Haven Brandon A; Martins V; Jury A; Popov S; Gowan S; Jeay S; Raynaud FI; Hofmann F; Hargrave D; Eccles SA; Jones C
    Mol Cancer Ther; 2011 Aug; 10(8):1407-18. PubMed ID: 21659463
    [TBL] [Abstract][Full Text] [Related]  

  • 40. STAT3 and HIF1α cooperatively activate HIF1 target genes in MDA-MB-231 and RCC4 cells.
    Pawlus MR; Wang L; Hu CJ
    Oncogene; 2014 Mar; 33(13):1670-9. PubMed ID: 23604114
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.